Fisher Stewart
Insider CIK 1824863 · CCCC Chief Scientific Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CCCC C4 Therapeutics, Inc. | M Exercise deriv | 2024-09-16 | 2024-09-17 | 2,250 | — | $0 | 14,250 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | F Tax w/h | 2024-09-16 | 2024-09-17 | 661 | $6.36 | $4.2K | 130,710 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | M Exercise | 2024-09-16 | 2024-09-17 | 2,250 | — | $0 | 131,371 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | A Award deriv | 2024-03-07 | 2024-03-08 | 94,950 | — | $0 | 94,950 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | D To issuer deriv | 2024-03-07 | 2024-03-08 | 118,000 | — | $0 | 0 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | A Award deriv | 2024-03-07 | 2024-03-08 | 118,000 | — | $0 | 118,000 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | D To issuer deriv | 2024-03-07 | 2024-03-08 | 94,950 | — | $0 | 0 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | A Award deriv | 2024-02-14 | 2024-02-15 | 122,800 | — | $0 | 122,800 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | A Award | 2024-02-14 | 2024-02-15 | 27,300 | — | $0 | 129,121 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | F Tax w/h | 2024-02-13 | 2024-02-15 | 2,255 | $6.53 | $14.7K | 101,821 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | A Award deriv | 2023-09-18 | 2023-09-19 | 120,000 | — | $0 | 120,000 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | M Exercise deriv | 2023-08-30 | 2023-08-31 | 2,250 | — | $0 | 16,500 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | M Exercise | 2023-08-30 | 2023-08-31 | 2,250 | — | $0 | 104,737 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | F Tax w/h | 2023-08-30 | 2023-08-31 | 661 | $2.93 | $1.9K | 104,076 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | A Award deriv | 2023-02-13 | 2023-02-15 | 125,000 | — | $0 | 125,000 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | A Award | 2023-02-13 | 2023-02-15 | 26,000 | — | $0 | 102,487 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | M Exercise deriv | 2023-01-30 | 2023-02-01 | 3,750 | — | $0 | 18,750 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | F Tax w/h | 2023-01-30 | 2023-02-01 | 1,301 | $7.78 | $10.1K | 76,487 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | M Exercise | 2023-01-30 | 2023-02-01 | 3,750 | — | $0 | 77,788 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | F Tax w/h | 2022-05-26 | 2022-06-14 | 1,102 | $7.01 | $7.7K | 74,038 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | M Exercise deriv | 2022-05-25 | 2022-05-27 | 3,750 | — | $0 | 22,500 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | M Exercise | 2022-05-25 | 2022-05-27 | 3,750 | — | $0 | 75,140 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | M Exercise deriv | 2022-04-12 | 2022-04-12 | 2,156 | — | $0 | 35,572 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | M Exercise deriv | 2022-04-12 | 2022-04-12 | 25,928 | — | $0 | 48,152 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | M Exercise | 2022-04-12 | 2022-04-12 | 2,156 | $3.71 | $8.0K | 45,462 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | M Exercise | 2022-04-12 | 2022-04-12 | 25,928 | $4.98 | $129.1K | 71,390 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | A Award deriv | 2022-02-14 | 2022-02-16 | 26,250 | — | $0 | 26,250 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | A Award deriv | 2022-02-14 | 2022-02-16 | 118,000 | — | $0 | 118,000 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | M Exercise deriv | 2021-12-08 | 2021-12-10 | 17,786 | — | $0 | 37,728 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | M Exercise deriv | 2021-12-08 | 2021-12-10 | 2,373 | — | $0 | 0 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | M Exercise deriv | 2021-12-08 | 2021-12-10 | 403 | — | $0 | 203,994 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | M Exercise | 2021-12-08 | 2021-12-10 | 2,373 | $2.11 | $5.0K | 25,117 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | M Exercise | 2021-12-08 | 2021-12-10 | 17,786 | $3.71 | $66.0K | 42,903 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | M Exercise | 2021-12-08 | 2021-12-10 | 403 | $4.98 | $2.0K | 43,306 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | S Sale | 2021-08-03 | 2021-08-05 | 17,057 | $45.01 | $767.7K | 22,744 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | S Sale | 2021-08-02 | 2021-08-02 | 18,104 | $45.00 | $814.7K | 39,801 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | S Sale | 2021-07-29 | 2021-08-02 | 50,211 | $45.00 | $2.26M | 57,905 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | A Award deriv | 2021-02-11 | 2021-02-16 | 94,950 | — | $0 | 94,950 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | M Exercise deriv | 2021-02-03 | 2021-02-04 | 5,929 | — | $0 | 55,514 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | M Exercise deriv | 2021-02-03 | 2021-02-04 | 2,371 | — | $0 | 2,371 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | M Exercise | 2021-02-03 | 2021-02-04 | 2,371 | $2.11 | $5.0K | 102,187 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | M Exercise | 2021-02-03 | 2021-02-04 | 5,929 | $3.71 | $22.0K | 108,116 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | M Exercise deriv | 2020-12-11 | 2021-02-04 | 4,743 | — | $0 | 4,742 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | M Exercise deriv | 2020-12-11 | 2021-02-04 | 9,701 | — | $0 | 61,443 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | M Exercise | 2020-12-11 | 2021-02-04 | 4,743 | $2.11 | $10.0K | 90,115 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | M Exercise | 2020-12-11 | 2021-02-04 | 9,701 | $3.71 | $36.0K | 99,816 | SEC↗ |